1. Brazil Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Blau Farmacêutica S.A.

Blau Farmacêutica S.A.

BLAU3.SA
Blau Farmacêutica S.A.BR flagB3 S.A.
10.05
BRL
-0.07
- -
2.32BMarket Cap

Total Valuation

Blau Farmacêutica S.A. carries a market capitalization of 2.32B, placing it among publicly traded companies globally. Its enterprise value stands at 2.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.32B
Enterprise Value2.37B

Share Statistics

Blau Farmacêutica S.A. currently has 230.98M shares outstanding.

Shares Outstanding230.98M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Blau Farmacêutica S.A. trades at a trailing price-to-earnings ratio of 9.73. The price-to-sales ratio is 1.34, and the price-to-book ratio stands at 1.35.

PE Ratio9.73
PS Ratio1.34
PB Ratio1.35
P/TBV Ratio1.45
P/FCF Ratio7.43
P/OCF Ratio8.58

Enterprise Valuation

On an enterprise value basis, Blau Farmacêutica S.A. trades at an EV/EBITDA multiple of 7.21 and an EV/FCF ratio of 5.79. The EV/Sales ratio of 1.34 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.21 provides insight into valuation relative to core operating earnings.

EV / Sales1.34
EV / EBITDA7.21
EV / EBIT7.21
EV / FCF5.79

Financial Position

Blau Farmacêutica S.A. maintains a current ratio of 2.66, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.63, indicating elevated leverage, while an interest coverage ratio of 2.71 demonstrates limited ability to service its debt obligations.

Current Ratio2.66
Quick Ratio0.79
Debt / Equity24.63
Debt / EBITDA1.70
Interest Coverage2.71

Financial Efficiency

Blau Farmacêutica S.A. posts a return on equity of 15.41 and a return on invested capital of 8.82.

Return on Equity (ROE)15.41
Return on Assets (ROA)6.96
Return on Invested Capital (ROIC)8.82
Return on Capital Employed (ROCE)15.81
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.54

Taxes

Over the trailing twelve months, Blau Farmacêutica S.A. has paid 83.48M in income taxes, reflecting an effective tax rate of 25.62.

Income Tax83.48M
Effective Tax Rate25.62

Stock Price Statistics

Blau Farmacêutica S.A.'s stock has gained approximately 1.82371% over the past 52 weeks. The 50-day moving average sits at 10.29, while the 200-day moving average is 10.22.

Beta (5Y)N/A
52-Week Price Change1.82371%
50-Day Moving Average10.29
200-Day Moving Average10.22
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Blau Farmacêutica S.A. generated 1.76B in revenue and converted that into 243.79M in net income, yielding earnings per share of 1.05. EBITDA reached 328.92M, while operating income came in at 328.92M.

Revenue1.76B
Gross Profit713.50M
Operating Income328.92M
Pretax Income325.85M
Net Income243.79M
EBITDA328.92M
EBIT328.92M
Earnings Per Share (EPS)1.05

Balance Sheet

Blau Farmacêutica S.A. holds 542.18M in cash and equivalents against 560.29M in total debt, resulting in a net debt position of 470.64M. Total book value stands at 1.76B, with working capital of 1.14B providing operational flexibility.

Cash & Cash Equivalents542.18M
Total Debt560.29M
Net Debt470.64M
Equity (Book Value)1.76B
Book Value Per Share7.60
Working Capital1.14B

Cash Flow

Blau Farmacêutica S.A. produced 276.63M in operating cash flow over the past twelve months. After subtracting -42.67M in capital expenditures, free cash flow totaled 233.96M - equivalent to 1.01 per share.

Operating Cash Flow276.63M
Capital Expenditures-42.67M
Free Cash Flow233.96M
FCF Per Share1.01

Margins

Blau Farmacêutica S.A. operates with a gross margin of 40.44, reflecting its pricing power and cost economics. The operating margin of 18.64 and net profit margin of 13.82 provide insight into operational efficiency.

Gross Margin40.44
Operating Margin18.64
Pretax Margin18.47
Profit Margin13.82
EBITDA Margin18.64

Dividends & Yields

The company's payout ratio of 26.03 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.27
Dividend YieldN/A
Payout Ratio26.03
Shareholder Yield5.56
FCF Yield13.46

Stock Splits

Blau Farmacêutica S.A.'s most recent stock split took place on January 6, 2026 with a 10:13 split ratio.

Last Split Date1/6/2026
Split Ratio10:13

Scores

Blau Farmacêutica S.A. posts an Altman Z-Score of 2.55, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.55